pone.0215861.g001.tif (291 kB)

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases - Fig 1

figure

posted on 2019-04-23, 17:37 authored by Zhijian Zhao, Wenqi Wu, Xiaolu Duan, Guohua Zeng, Yongda Liu

(A) Overall survival and (B) cumulative incidence of renal cell carcinoma (RCC)-specific mortality in patients with metastatic RCC at diagnosis based on treatment received in full samples. NS = no surgery therapy; CN = cytoreductive nephrectomy.

History

Usage metrics

Read the peer-reviewed publication

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases

PLOS ONE

Keywords

cytoreductive nephrectomy OS risks regression analysis site-specific metastases Background CSM NS CN

Licence

CC BY 4.0